03
May
2009
Posted in I - Series B, Q - 2Q09, R - NORTH EAST, X - CNS, X - Depression, X - PTSD, X - Seizures, XX - CT
Marinus Pharmaceuticals (Branford, CT) a clinical-stage company focused on reformulation and development of therapeutics for the treatment of CNS, psychiatric and pain disorders, closed a $20M Series B financing. Participants include Canaan Partners, Domain Associates, Sofinnova Ventures and Foundation Medical Partners.
30
Mar
2009
Posted in I - Series B, Q - 1Q09, R - SOUTH EAST, X - Epilepsy, X - Pain, X - Seizures, XX - KY
Ikano Therapeutics (Lexington, KY) a clinical-stage nasal delivery platform company focused on seizures and pain, closed a $9M Series B financing, the final tranche of a $18M round. Participants include SV Life Sciences, Burrill & Co., Tullis-Dickerson, Fidelity Biosciences, Apjohn Ventures, Fort Washington Capital, Commonwealth Seed Capital and Kentucky Co-Investment Partners.